Big Blue has found yet another business application for its precocious cognitive computing system. IBMWatson Health is collaborating with the biopharmaceutical company Celgene to develop a new platform for evaluating the safety of drugs—both before and after they hit the market—the two companies are announcing this morning. Read more . . .
IBM Watson Health tries to do what no pharma company has done: solve the drug-safety puzzle.